New

Women Health Care Market

2021

Women Health Care Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Drug (XGEVA, Mirena, EVISTA, Prolia, Zometa, Reclast/Aclasta, Minastrin 24 Fe, NuvaRing, Premarin, FORTEO, ACTONEL, and Others); Application (Postmenopausal Osteoporosis, Menopause, Endometriosis, Hormonal Infertility, Contraceptives, and Other); Distribution Channel (Hospital Pharmacies, Drug Stores and Retail pharmacies, and Online Providers), and Geography

| Report Code: TIPRE00024010 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Women Health Care Market 2028 By Drug, Application, Distribution Channel, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Women's healthcare includes complete emphasis and focuses on the wellbeing of the women by ensuring appropriate diagnosis and treatment. Women experience various problems during and postmenstrual cycle, which is common amongst women. Furthermore, the most prevalent diseases among women include various urological disorders, polycystic ovarian syndrome, and other post-menopausal complications. Multiple medications are available for controlling birth and regulating hormones, which is a significant challenge. During pregnancy and post-pregnancy, the hormonal disturbances are experienced by most women, the management of which is essential and is in demand for the next few years.

MARKET SCOPE

The "Global Women Health Care Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Women health care market with detailed market segmentation by drug, application, distribution channel, and geography. The report provides key statistics on the market status of the leading Women health care market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

    - Based on drug, the global Women health care market is segmented into xgeva, mirena, evista, prolia, zometa, reclast/aclasta, minastrin 24 fe, nuvaring, premarin, forteo, actonel, and others.
    - On the basis of application, the market is segmented into postmenopausal osteoporosis, menopause, endometriosis, hormonal infertility, contraceptives, and other.
    - On the basis of distribution channel, the market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online providers.

MARKET DYNAMICS
Drivers:

    - Rise in the incidences of chronic health condition among women.
    - Rise in the demand for contraceptives to prevent unintended pregnancies.
    - Increasing government initiatives to control population growth.

Restraints:

    - The harmful effects of women healthcare products are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Women health care market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

BThe report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Women health care market in these regions.

IMPACT OF COVID-19 ON WOMEN HEALTH CARE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Women health care market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Women health care market are anticipated to lucrative growth opportunities in the future with the rising demand for Women health care in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Women health care market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

    - Bayer AG
    - Allergan
    - Merck & Co.
    - Pfizer Inc.
    - Amgen
    - Agile Therapeutics Inc.
    - Ferring Pharmaceuticals
    - Mylan N.V.
    - Lupin
    - Blairex Laboratories

The Insight Partner's dediWomen health careed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Women Health Care Market - By Drug
1.3.2 Women Health Care Market - By Application
1.3.3 Women Health Care Market - By Distribution Channel
1.3.4 Women Health Care Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. WOMEN HEALTH CARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. WOMEN HEALTH CARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. WOMEN HEALTH CARE MARKET - GLOBAL MARKET ANALYSIS
6.1. WOMEN HEALTH CARE - GLOBAL MARKET OVERVIEW
6.2. WOMEN HEALTH CARE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. WOMEN HEALTH CARE MARKET - REVENUE AND FORECASTS TO 2028 - DRUG
7.1. OVERVIEW
7.2. DRUG MARKET FORECASTS AND ANALYSIS
7.3. XGEVA
7.3.1. Overview
7.3.2. XGEVA Market Forecast and Analysis
7.4. MIRENA
7.4.1. Overview
7.4.2. Mirena Market Forecast and Analysis
7.5. EVISTA
7.5.1. Overview
7.5.2. EVISTA Market Forecast and Analysis
7.6. PROLIA
7.6.1. Overview
7.6.2. Prolia Market Forecast and Analysis
7.7. ZOMETA
7.7.1. Overview
7.7.2. Zometa Market Forecast and Analysis
7.8. RECLAST/ACLASTA
7.8.1. Overview
7.8.2. Reclast/Aclasta Market Forecast and Analysis
7.9. MINASTRIN 24 FE
7.9.1. Overview
7.9.2. Minastrin 24 Fe Market Forecast and Analysis
7.10. NUVARING
7.10.1. Overview
7.10.2. NuvaRing Market Forecast and Analysis
7.11. PREMARIN
7.11.1. Overview
7.11.2. Premarin Market Forecast and Analysis
7.12. FORTEO
7.12.1. Overview
7.12.2. FORTEO Market Forecast and Analysis
7.13. ACTONEL
7.13.1. Overview
7.13.2. ACTONEL Market Forecast and Analysis
7.14. OTHERS
7.14.1. Overview
7.14.2. Others Market Forecast and Analysis
8. WOMEN HEALTH CARE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. POSTMENOPAUSAL OSTEOPOROSIS
8.3.1. Overview
8.3.2. Postmenopausal Osteoporosis Market Forecast and Analysis
8.4. MENOPAUSE
8.4.1. Overview
8.4.2. Menopause Market Forecast and Analysis
8.5. ENDOMETRIOSIS
8.5.1. Overview
8.5.2. Endometriosis Market Forecast and Analysis
8.6. HORMONAL INFERTILITY
8.6.1. Overview
8.6.2. Hormonal Infertility Market Forecast and Analysis
8.7. CONTRACEPTIVES
8.7.1. Overview
8.7.2. Contraceptives Market Forecast and Analysis
8.8. OTHER
8.8.1. Overview
8.8.2. Other Market Forecast and Analysis
9. WOMEN HEALTH CARE MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. DRUG STORES AND RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Drug Stores and Retail pharmacies Market Forecast and Analysis
9.5. ONLINE PROVIDERS
9.5.1. Overview
9.5.2. Online Providers Market Forecast and Analysis
10. WOMEN HEALTH CARE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Women Health Care Market Overview
10.1.2 North America Women Health Care Market Forecasts and Analysis
10.1.3 North America Women Health Care Market Forecasts and Analysis - By Drug
10.1.4 North America Women Health Care Market Forecasts and Analysis - By Application
10.1.5 North America Women Health Care Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Women Health Care Market Forecasts and Analysis - By Countries
10.1.6.1 United States Women Health Care Market
10.1.6.1.1 United States Women Health Care Market by Drug
10.1.6.1.2 United States Women Health Care Market by Application
10.1.6.1.3 United States Women Health Care Market by Distribution Channel
10.1.6.2 Canada Women Health Care Market
10.1.6.2.1 Canada Women Health Care Market by Drug
10.1.6.2.2 Canada Women Health Care Market by Application
10.1.6.2.3 Canada Women Health Care Market by Distribution Channel
10.1.6.3 Mexico Women Health Care Market
10.1.6.3.1 Mexico Women Health Care Market by Drug
10.1.6.3.2 Mexico Women Health Care Market by Application
10.1.6.3.3 Mexico Women Health Care Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Women Health Care Market Overview
10.2.2 Europe Women Health Care Market Forecasts and Analysis
10.2.3 Europe Women Health Care Market Forecasts and Analysis - By Drug
10.2.4 Europe Women Health Care Market Forecasts and Analysis - By Application
10.2.5 Europe Women Health Care Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Women Health Care Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Women Health Care Market
10.2.6.1.1 Germany Women Health Care Market by Drug
10.2.6.1.2 Germany Women Health Care Market by Application
10.2.6.1.3 Germany Women Health Care Market by Distribution Channel
10.2.6.2 France Women Health Care Market
10.2.6.2.1 France Women Health Care Market by Drug
10.2.6.2.2 France Women Health Care Market by Application
10.2.6.2.3 France Women Health Care Market by Distribution Channel
10.2.6.3 Italy Women Health Care Market
10.2.6.3.1 Italy Women Health Care Market by Drug
10.2.6.3.2 Italy Women Health Care Market by Application
10.2.6.3.3 Italy Women Health Care Market by Distribution Channel
10.2.6.4 Spain Women Health Care Market
10.2.6.4.1 Spain Women Health Care Market by Drug
10.2.6.4.2 Spain Women Health Care Market by Application
10.2.6.4.3 Spain Women Health Care Market by Distribution Channel
10.2.6.5 United Kingdom Women Health Care Market
10.2.6.5.1 United Kingdom Women Health Care Market by Drug
10.2.6.5.2 United Kingdom Women Health Care Market by Application
10.2.6.5.3 United Kingdom Women Health Care Market by Distribution Channel
10.2.6.6 Rest of Europe Women Health Care Market
10.2.6.6.1 Rest of Europe Women Health Care Market by Drug
10.2.6.6.2 Rest of Europe Women Health Care Market by Application
10.2.6.6.3 Rest of Europe Women Health Care Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Women Health Care Market Overview
10.3.2 Asia-Pacific Women Health Care Market Forecasts and Analysis
10.3.3 Asia-Pacific Women Health Care Market Forecasts and Analysis - By Drug
10.3.4 Asia-Pacific Women Health Care Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Women Health Care Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Women Health Care Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Women Health Care Market
10.3.6.1.1 Australia Women Health Care Market by Drug
10.3.6.1.2 Australia Women Health Care Market by Application
10.3.6.1.3 Australia Women Health Care Market by Distribution Channel
10.3.6.2 China Women Health Care Market
10.3.6.2.1 China Women Health Care Market by Drug
10.3.6.2.2 China Women Health Care Market by Application
10.3.6.2.3 China Women Health Care Market by Distribution Channel
10.3.6.3 India Women Health Care Market
10.3.6.3.1 India Women Health Care Market by Drug
10.3.6.3.2 India Women Health Care Market by Application
10.3.6.3.3 India Women Health Care Market by Distribution Channel
10.3.6.4 Japan Women Health Care Market
10.3.6.4.1 Japan Women Health Care Market by Drug
10.3.6.4.2 Japan Women Health Care Market by Application
10.3.6.4.3 Japan Women Health Care Market by Distribution Channel
10.3.6.5 South Korea Women Health Care Market
10.3.6.5.1 South Korea Women Health Care Market by Drug
10.3.6.5.2 South Korea Women Health Care Market by Application
10.3.6.5.3 South Korea Women Health Care Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Women Health Care Market
10.3.6.6.1 Rest of Asia-Pacific Women Health Care Market by Drug
10.3.6.6.2 Rest of Asia-Pacific Women Health Care Market by Application
10.3.6.6.3 Rest of Asia-Pacific Women Health Care Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Women Health Care Market Overview
10.4.2 Middle East and Africa Women Health Care Market Forecasts and Analysis
10.4.3 Middle East and Africa Women Health Care Market Forecasts and Analysis - By Drug
10.4.4 Middle East and Africa Women Health Care Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Women Health Care Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Women Health Care Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Women Health Care Market
10.4.6.1.1 South Africa Women Health Care Market by Drug
10.4.6.1.2 South Africa Women Health Care Market by Application
10.4.6.1.3 South Africa Women Health Care Market by Distribution Channel
10.4.6.2 Saudi Arabia Women Health Care Market
10.4.6.2.1 Saudi Arabia Women Health Care Market by Drug
10.4.6.2.2 Saudi Arabia Women Health Care Market by Application
10.4.6.2.3 Saudi Arabia Women Health Care Market by Distribution Channel
10.4.6.3 U.A.E Women Health Care Market
10.4.6.3.1 U.A.E Women Health Care Market by Drug
10.4.6.3.2 U.A.E Women Health Care Market by Application
10.4.6.3.3 U.A.E Women Health Care Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Women Health Care Market
10.4.6.4.1 Rest of Middle East and Africa Women Health Care Market by Drug
10.4.6.4.2 Rest of Middle East and Africa Women Health Care Market by Application
10.4.6.4.3 Rest of Middle East and Africa Women Health Care Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Women Health Care Market Overview
10.5.2 South and Central America Women Health Care Market Forecasts and Analysis
10.5.3 South and Central America Women Health Care Market Forecasts and Analysis - By Drug
10.5.4 South and Central America Women Health Care Market Forecasts and Analysis - By Application
10.5.5 South and Central America Women Health Care Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Women Health Care Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Women Health Care Market
10.5.6.1.1 Brazil Women Health Care Market by Drug
10.5.6.1.2 Brazil Women Health Care Market by Application
10.5.6.1.3 Brazil Women Health Care Market by Distribution Channel
10.5.6.2 Argentina Women Health Care Market
10.5.6.2.1 Argentina Women Health Care Market by Drug
10.5.6.2.2 Argentina Women Health Care Market by Application
10.5.6.2.3 Argentina Women Health Care Market by Distribution Channel
10.5.6.3 Rest of South and Central America Women Health Care Market
10.5.6.3.1 Rest of South and Central America Women Health Care Market by Drug
10.5.6.3.2 Rest of South and Central America Women Health Care Market by Application
10.5.6.3.3 Rest of South and Central America Women Health Care Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL WOMEN HEALTH CARE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. WOMEN HEALTH CARE MARKET, KEY COMPANY PROFILES
13.1. BAYER AG
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MERCK AND CO.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PFIZER INC.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. AMGEN
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. AGILE THERAPEUTICS INC.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. FERRING PHARMACEUTICALS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. MYLAN N.V.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. LUPIN
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. BLAIREX LABORATORIES
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Bayer AG
2. Allergan
3. Merck & Co.
4. Pfizer Inc.
5. Amgen
6. Agile Therapeutics Inc.
7. Ferring Pharmaceuticals
8. Mylan N.V.
9. Lupin
10. Blairex Laboratories
11. Apothecus Pharmaceutical
12. Eli Lilly and Company
13. Novartis AG
14. Johnson & Johnson
15. AstraZeneca
16. Bristol-Myers Squib
TIPRE00024010
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.